scholarly article | Q13442814 |
P356 | DOI | 10.1097/00006123-199011000-00010 |
P698 | PubMed publication ID | 2259403 |
P2093 | author name string | Anderson DE | |
Origitano TC | |||
Reichman OH | |||
Wascher TM | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebral blood flow | Q5064096 |
P304 | page(s) | 729-39; discussion 739-40 | |
P577 | publication date | 1990-11-01 | |
P1433 | published in | Neurosurgery | Q7002693 |
P1476 | title | Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage | |
P478 | volume | 27 |
Q35088321 | A proposed definition of symptomatic vasospasm based on treatment of cerebral vasospasm after subarachnoid hemorrhage in Japan: Consensus 2009, a project of the 25 Spasm Symposium |
Q42170523 | Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. |
Q81330059 | Cerebral Vasospasm in Subarachnoid Hemorrhage |
Q36390897 | Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management |
Q48187288 | Changes in Cerebral Perfusion with Induced Hypertension in Aneurysmal Subarachnoid Hemorrhage: A Pilot and Feasibility Study. |
Q37148901 | Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage |
Q43764373 | Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience |
Q46763779 | Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage? |
Q71765279 | Early aneurysm surgery and dehydration therapy in patients with severe subarachnoid haemorrhage without ICH |
Q47244570 | Effect of HHH-Therapy on Regional CBF after Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT. |
Q37696595 | Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review |
Q41892493 | Effects of ischemic phrenic nerve root ganglion injury on respiratory disturbances in subarachnoid hemorrhage: an experimental study |
Q37904848 | Hemodynamic management of subarachnoid hemorrhage |
Q49979487 | Hydroxyethyl starch for volume expansion after subarachnoid haemorrhage and renal function: Results of a retrospective analysis |
Q48278288 | Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH. |
Q37249305 | Intracarotid delivery of drugs: the potential and the pitfalls |
Q48520728 | Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat. |
Q28076405 | Management of delayed cerebral ischemia after subarachnoid hemorrhage |
Q37119782 | Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
Q28254203 | Novel treatment targets for cerebral edema |
Q39850027 | Perfusion-weighted MRI to evaluate cerebral autoregulation in aneurysmal subarachnoid haemorrhage |
Q42141652 | Persistent autoregulatory disturbance after angioplasty for cerebral vasospasm. A case report |
Q35574105 | Pharmacological treatment of delayed cerebral ischemia and vasospasm in subarachnoid hemorrhage |
Q81206499 | Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol |
Q51964531 | Relative changes in flow velocities in vasospasm after subarachnoid hemorrhage: a transcranial Doppler study. |
Q37900216 | Routine management of volume status after aneurysmal subarachnoid hemorrhage |
Q70665796 | Selective angiography for early aneurysm detection in acute subarachnoid haemorrhage |
Q52571336 | Spinal Cerebrospinal Fluid Drainage for prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized controlled study. |
Q36369699 | Statins in the critically ill |
Q30472868 | Stellate ganglion block for treatment of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage - A preliminary study |
Q35749485 | Subarachnoid hemorrhage in Kashmir: Causes, risk factors, and outcome |
Q55042825 | The Factors Associated with Outcomes in Surgically Managed Ruptured Cerebral Aneurysm. |
Q33937019 | The association between fluid balance and outcomes after subarachnoid hemorrhage |
Q36813472 | The impact of a highly visible display of cerebral perfusion pressure on outcome in individuals with cerebral aneurysms |
Q40861308 | Vasodilators during cerebral aneurysm surgery |
Q40528061 | Vasospasm after resection of skull base tumors |
Search more.